Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Zoledronic Acid,Inapplicable
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : DKSH
Deal Size : Undisclosed
Deal Type : Partnership
DKSH Has Successfully Entered into a Strategic Partnership with SciGen in Vietnam
Details : DKSH has enetered a strategic partnership with SciGen to supply Zometa (zoledronic acid) to the Vietnamese market. it is indicated for the treatment of Advanced cancers.
Product Name : Zometa
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 21, 2023
Lead Product(s) : Zoledronic Acid,Inapplicable
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : DKSH
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : Hepatitis B Vaccine Recombinant,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Recipient : Tel Aviv Sourasky Medical Center (Ichilov Hospital)
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficiency of the Hepatitis B Sci-B-Vac Vaccine in HIV Positive Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
September 21, 2011
Lead Product(s) : Hepatitis B Vaccine Recombinant,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Recipient : Tel Aviv Sourasky Medical Center (Ichilov Hospital)
Deal Size : Inapplicable
Deal Type : Inapplicable